1.Initial 3-month dynamics of dehydroepiandrosterone sulfate can predict responsiveness to primary androgen deprivation therapy in patients with metastatic prostate cancer.
Akihiro YANO ; Makoto KAGAWA ; Hideki TAKESHITA ; Yohei OKADA ; Makoto MOROZUMI ; Satoru KAWAKAMI
Asian Journal of Andrology 2019;21(6):635-636